This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Web of Science (31) Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Nutt, D. J. Search for Related Content PubMed PubMed Citation Articles by Nutt, D. J. Pubmed/NCBI databases Medline Plus Health Information Drug Abuse Suicide Social Bookmarking                         What's this?

Death and Dependence: Current Controversies over the Selective Serotonin Reuptake Inhibitors

University of Bristol, Psychopharmacology Unit, School of Medical Sciences, University Walk, Bristol, UK.david.j.nutt{at}bristol.ac.uk

Recent years have seen a considerable media interest in the adverse effects of the selective serotonin reuptake inhibitors (SSRIs). This has led to claims that these antidepressants may lead to suicide and homicide and that they cause dependence or even addiction. Such claims have caused great concerns to many patients and have confused doctors in both primary care and psychiatric practice. In this article I review the basis of these claims and show that many seem to emerge from the misinterpretation of evidence and the use of imprecise definitions. Although the SSRIs are not free of problems they compare very favourably with other antidepressants and other classes of psychotropic drugs. There is no evidence they are addictive in the formal sense of leading to a drug dependence syndrome. Some suggestions on the way these issues can be more precisely defined and studied in future are given.

Key Words: antidepressants • benzodiazepines • dependence • depression • selective serotonin reuptake inhibitors • suicide • withdrawal

Journal of Psychopharmacology, Vol. 17, No. 4, 355-364 (2003)
DOI: 10.1177/0269881103174019


CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				P. Blier and D. Nutt Reply from the Editors J Psychopharmacol, August 1, 2007; 21(6): 670 - 670. [PDF]

				C. B. Raymond, S. G. Morgan, and P. A. Caetano Antidepressant Utilization in British Columbia From 1996 to 2004: Increasing Prevalence but Not Incidence Psychiatr Serv, January 1, 2007; 58(1): 79 - 84. [Abstract] [Full Text] [PDF]

				D. N. Juurlink, M. M. Mamdani, A. Kopp, and D. A. Redelmeier The Risk of Suicide With Selective Serotonin Reuptake Inhibitors in the Elderly Am J Psychiatry, May 1, 2006; 163(5): 813 - 821. [Abstract] [Full Text] [PDF]

				A J Mitchell and M Dennis Self harm and attempted suicide in adults: 10 practical questions and answers for emergency department staff. Emerg. Med. J., April 1, 2006; 23(4): 251 - 255. [Abstract] [Full Text] [PDF]

				D. S. Baldwin, I. M. Anderson, D. J. Nutt, B. Bandelow, A. Bond, J. R. T. Davidson, J. A. den Boer, N. A. Fineberg, M. Knapp, J. Scott, et al. Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology J Psychopharmacol, November 1, 2005; 19(6): 567 - 596. [Abstract] [PDF]

				D. Gunnell, J. Saperia, and D. Ashby Do selective serotonin reuptake inhibitors cause suicide?: Authors' reply to Curtin and Schulz, and Healy BMJ, May 14, 2005; 330(7500): 1148 - 1149. [Full Text]

				D. J. Nutt Death by tricyclic: the real antidepressant scandal? J Psychopharmacol, March 1, 2005; 19(2): 123 - 124. [PDF]

				D. Gunnell, J. Saperia, and D. Ashby Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review BMJ, February 19, 2005; 330(7488): 385. [Abstract] [Full Text] [PDF]

				A. R. Lingford-Hughes, S. Welch, and D. J. Nutt Evidence-Based Guidelines for the Pharmacological Management of Substance Misuse, Addiction and Comorbidity: Recommendations from the British Association for Psychopharmacology J Psychopharmacol, September 1, 2004; 18(3): 293 - 335. [PDF]

				T. Berney Asperger syndrome from childhood into adulthood Adv. Psychiatr. Treat., September 1, 2004; 10(5): 341 - 351. [Abstract] [Full Text] [PDF]

				A. J Mitchell Antidepressants and suicide: Risk of completed suicide is not the same as risk of deliberate self harm BMJ, August 21, 2004; 329(7463): 461 - 461. [Full Text]

				S. Wessely and R. Kerwin Suicide Risk and the SSRIs JAMA, July 21, 2004; 292(3): 379 - 381. [Full Text] [PDF]

				D. Gunnell and D. Ashby Antidepressants and suicide: what is the balance of benefit and harm BMJ, July 3, 2004; 329(7456): 34 - 38. [Full Text] [PDF]

				D. Healy and G. Aldred Death, Dependence and Deception J Psychopharmacol, June 1, 2004; 18(2): 285 - 287. [PDF]